Coronavirus Disease (COVID-19)
COVID-19 - Inpatient Therapies - Clinical Pathway
COVID-19 - Outpatient Therapies - Clinical Pathway
Multi-System Inflammatory Syndrome in Children (MIS-C)
Community-onset Bacterial Meningitis
Fever & Sepsis Evaluation in the Neonate (0-28 days) - Clinical Pathway
Fever & Sepsis Evaluation in Infant (29-60 days) - Clinical Pathway
Healthcare-associated Ventriculitis and Meningitis
HIV-Post Exposure Prophylaxis - Clinical Pathway
Lyme (Blood, Heart & Brain manifestations)
Oncology Patient with Fever - Clinical Pathway
Rocky Mountain Spotted Fever
Sickle Cell Patient with Fever - Clinical Pathway
Suspected Neurosurgical Shunt Infection - Clinical Pathway
Animal Bite Skin Soft Tissue Infection - Clinical Pathway
Antimicrobial Prophylaxis for Surgery
Lyme Arthritis
Osteomyelitis
Skin and Soft Tissue Infection (SSTI) - Clinical Pathway
Staphylococcal Scalded Skin Syndrome
Tinea capitis
Tinea corporis
Toxic Shock Syndrome
Varicella
Acute Otitis Media (AOM)
Aspiration Pneumonia
Community Acquired Pneumonia - Clinical Pathway
Cystic Fibrosis Exacerbation
Group A Streptococcus Pharyngitis
Healthcare / Ventilator Associated Pneumonia
Influenza
Peritonsillar Abscess / Head and Neck Infections
Pertussis
Preseptal & Orbital Cellulitis - Clinical Pathway
Sinusitis
Thrush
Tracheitis in Trached Patients
Appendicitis - Clinical Pathway
Bacterial Vaginosis
Chlamydia
Cholecystitis
Clostridium difficile (C. difficile) Infection - Clinical Pathway
Genital Herpes
Gonorrhea
Non-Gonococcal Urethritis & Cervicitis
Pelvic Inflammatory Disease
Peritonitis
Syphilis
Trichomoniasis
Urinary Tract Infections - Clinical Pathway
NICU Sepsis Evaluations and Antimicrobial Use
IV Antimicrobials Monitoring
Beta-Lactam Allergy Guidance
IV to PO Conversion
